Literature DB >> 15509511

Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.

Won-Kyung Cho1, Young Rim Seong, Yeune Hee Lee, Min Ji Kim, Kyung-Sun Hwang, Jinsang Yoo, Seeyoung Choi, Cho-Rok Jung, Dong-Soo Im.   

Abstract

Solid tumors contain normoxic and hypoxic regions depending on the distance from the capillary. Normal cells may also be exposed to hypoxia under certain physiological conditions. Tumor hypoxia has been shown to associate strongly with tumor propagation and malignant progression. Hypoxia-inducible factor (HIF)-1alpha is stable under hypoxia and induces transcription of target genes by binding to the hypoxia-response element (HRE). Here we investigated the oncolytic effects of a novel adenovirus mutant with a deleted E1B55 gene (Ad.Delta55.HRE), in which the expression of E1A, which is essential for adenoviral replication, is regulated under the control of an HRE-expression system. Ad.Delta55.HRE expressed E1A under normoxia and more E1A under hypoxia and exhibited oncolytic effects on various cultured tumor cells, but its cytotoxic effect is relatively attenuated in normal fibroblast cells under normoxic and hypoxic conditions. Ad.Delta55.HRE lysed Huh-7 hepatoma cells stably expressing HIF-1alpha more effectively compared to parental cells. Ad.Delta55.HRE treatment exhibited significant antitumor activity in PC-3 prostate- and MDA-MB-435 breast tumor-bearing nude mice in which HIF-1alpha protein was immunohistochemically detected. The E1A and hexon proteins of adenovirus were immunostained in MDA-MB-435 xenografts after Ad.Delta55.HRE treatment, suggestive of viral replication. Our results suggest that Ad.Delta55.HRE may be useful for the treatment of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509511     DOI: 10.1016/j.ymthe.2004.07.023

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  16 in total

1.  Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.

Authors:  C-S Lu; J-L Hsieh; C-Y Lin; H-W Tsai; B-H Su; G-S Shieh; Y-C Su; C-H Lee; M-Y Chang; C-L Wu; A-L Shiau
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

2.  Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells.

Authors:  Daizo Yoshida; Kyongson Kim; Masahiro Noha; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-07-30       Impact factor: 4.130

Review 3.  Impact of tumor microenvironment on oncolytic viral therapy.

Authors:  Jeffrey Wojton; Balveen Kaur
Journal:  Cytokine Growth Factor Rev       Date:  2010 Apr-Jun       Impact factor: 7.638

4.  The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.

Authors:  X Y Pan; X J Liu; J Li; S J Zhen; D X Liu; Q Feng; W X Zhao; Y Luo; Y L Zhang; H W Li; J L Yang
Journal:  Gene Ther       Date:  2016-12-22       Impact factor: 5.250

5.  Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.

Authors:  T Cherry; S L Longo; Z Tovar-Spinoza; D E Post
Journal:  Gene Ther       Date:  2010-07-22       Impact factor: 5.250

6.  Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

Authors:  Sergia Bortolanza; Maria Bunuales; Itziar Otano; Gloria Gonzalez-Aseguinolaza; Carlos Ortiz-de-Solorzano; Daniel Perez; Jesus Prieto; Ruben Hernandez-Alcoceba
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

Review 7.  Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Authors:  Z Sheng Guo; Stephen H Thorne; David L Bartlett
Journal:  Biochim Biophys Acta       Date:  2008-02-15

8.  Adenoviral vector-based strategies for cancer therapy.

Authors:  Anurag Sharma; Manish Tandon; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Drug ther       Date:  2009-05-01

9.  Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT).

Authors:  Ashish Misra; Chhiti Pandey; Siu Kwan Sze; Thirumaran Thanabalu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vector.

Authors:  Christopher J Dougherty; George W Smith; C Kathleen Dorey; Howard M Prentice; Keith A Webster; Janet C Blanks
Journal:  Mol Vis       Date:  2008-03-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.